Table 1.
E, experimental group; C, control group; PMO, postmenopausal osteoporosis; MOTION, the monthly oral therapy with ibandronate for osteoporosis intervention study; PERSIST, the persistence study of ibandronate versus alendronate; BALTO, the Bonviva alendronate trial in osteoporosis; MOBILE, the monthly oral ibandronate in ladies; BMD, bone mineral density; GI, gastrointestinal.